After last month’s departure of…
After last month’s departure of longtime executive Adam Pearson, Astellas [...]
An FDA expert panel on Thursday…
An FDA expert panel on Thursday voted 6 to 3 [...]
As Eli Lilly gets off to the races…
As Eli Lilly gets off to the races with the [...]
Bristol Myers Squibb’s growth…
Bristol Myers Squibb’s growth portfolio is offsetting declines in older [...]
While Merck’s PAH treatment…
While Merck’s PAH treatment Winrevair continued its upward trajectory, another [...]
Bristol Myers Squibb has called…
Bristol Myers Squibb has called time on a bispecific antibody [...]
Indivior ended internal…
Indivior ended internal development of an opioid use disorder candidate [...]
BeOne Medicines is paying $20…
BeOne Medicines is paying $20 million upfront to reserve the [...]
As AstraZeneca braces for the…
As AstraZeneca braces for the impact of the U.S. “most [...]
While Teva Pharmaceutical’s…
While Teva Pharmaceutical’s multiyear growth streak under CEO Richard Francis [...]